IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 35 filers reported holding IKENA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $857,392 | -26.3% | 198,012 | +11.7% | 0.00% | – |
| Q2 2023 | $1,163,376 | +995.2% | 177,344 | +476.0% | 0.00% | – |
| Q1 2023 | $106,225 | +47.3% | 30,790 | +13.5% | 0.00% | – |
| Q4 2022 | $72,137 | -25.6% | 27,119 | -0.4% | 0.00% | – |
| Q3 2022 | $97,000 | +40.6% | 27,234 | +76.5% | 0.00% | – |
| Q2 2022 | $69,000 | -94.4% | 15,434 | -92.3% | 0.00% | – |
| Q1 2022 | $1,228,000 | -53.0% | 201,180 | -3.3% | 0.00% | – |
| Q4 2021 | $2,610,000 | +125.4% | 208,065 | +126.8% | 0.00% | – |
| Q3 2021 | $1,158,000 | -3.0% | 91,757 | +7.9% | 0.00% | – |
| Q2 2021 | $1,194,000 | – | 85,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |